Annual Short Term Debt
$5.28 M
+$2.38 M+82.46%
30 September 2023
Summary:
Enanta Pharmaceuticals annual short term debt is currently $5.28 million, with the most recent change of +$2.38 million (+82.46%) on 30 September 2023. During the last 3 years, it has risen by +$1.07 million (+25.51%). ENTA annual short term debt is now at all-time high.ENTA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.43 M
-$1.15 M-32.11%
30 June 2024
Summary:
Enanta Pharmaceuticals quarterly short term debt is currently $2.43 million, with the most recent change of -$1.15 million (-32.11%) on 30 June 2024. Over the past year, it has dropped by -$2.84 million (-53.91%). ENTA quarterly short term debt is now -54.71% below its all-time high of $5.37 million, reached on 30 June 2023.ENTA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -53.9% |
| 3 y3 years | +25.5% | -42.2% |
| 5 y5 years | +100.0% | +100.0% |
ENTA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +82.5% | -54.7% | at low |
| 5 y | 5 years | at high | -54.7% | ||
| alltime | all time | at high | -54.7% |
Enanta Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $2.43 M(-32.1%) |
| Mar 2024 | - | $3.58 M(-27.9%) |
| Dec 2023 | - | $4.97 M(-5.9%) |
| Sept 2023 | $5.28 M(+82.5%) | $5.28 M(-1.7%) |
| June 2023 | - | $5.37 M(+9.0%) |
| Mar 2023 | - | $4.92 M(+41.2%) |
| Dec 2022 | - | $3.49 M(+20.6%) |
| Sept 2022 | $2.89 M(-31.2%) | $2.89 M(+11.2%) |
| June 2022 | - | $2.60 M(-13.7%) |
| Mar 2022 | - | $3.01 M(-13.1%) |
| Dec 2021 | - | $3.47 M(-17.5%) |
| Sept 2021 | $4.20 M | $4.20 M(-16.5%) |
| June 2021 | - | $5.03 M(-2.7%) |
| Mar 2021 | - | $5.17 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | - | $5.20 M(+22.0%) |
| Sept 2020 | $4.26 M(>+9900.0%) | $4.26 M(-0.1%) |
| June 2020 | - | $4.26 M(+13.3%) |
| Mar 2020 | - | $3.76 M(+20.2%) |
| Dec 2019 | - | $3.13 M(>+9900.0%) |
| Sept 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2017 | - | $75.00 K(0.0%) |
| Mar 2017 | - | $75.00 K(0.0%) |
| Dec 2016 | - | $75.00 K(+2.7%) |
| Sept 2016 | $73.00 K(+5.8%) | $73.00 K(+2.8%) |
| June 2016 | - | $71.00 K(+36.5%) |
| Mar 2016 | - | $52.00 K(-24.6%) |
| Dec 2015 | - | $69.00 K(0.0%) |
| Sept 2015 | $69.00 K(>+9900.0%) | $69.00 K(>+9900.0%) |
| Sept 2014 | $0.00 | $0.00 |
FAQ
- What is Enanta Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly short term debt year-on-year change?
What is Enanta Pharmaceuticals annual short term debt?
The current annual short term debt of ENTA is $5.28 M
What is the all time high annual short term debt for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual short term debt is $5.28 M
What is Enanta Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of ENTA is $2.43 M
What is the all time high quarterly short term debt for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly short term debt is $5.37 M
What is Enanta Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, ENTA quarterly short term debt has changed by -$2.84 M (-53.91%)